GlassScriptPhysician profile
April Anderson
NPI 1275980690
$1,392.75
in general payments reported to CMS, 2019-2025
19 companies · $23.71 in 2025
The $23.71 reported for 2025 was less than what a typical Nurse Practitioner provider received nationally (typical 2025 total: $174).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $792 · 2022: $275 · 2023: $302 · 2025: $23.71.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $326.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $325.76 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bausch Health US, LLC | $197.83 | 2021-2022 | |
| Sunovion Pharmaceuticals INC. | $188.33 | 2021 | |
| Alkermes, INC. | $166.23 | 2021-2023 | Aristada, Lybalvi |
| Takeda Pharmaceuticals U.S.A., INC. | $152.79 | 2021-2023 | Trintellix |
| Teva Pharmaceuticals USA, INC. | $105.14 | 2021-2023 | Uzedy |
| Neurocrine Biosciences, INC. | $99.60 | 2021-2023 | Ingrezza |
| Axsome Therapeutics, INC. | $85.18 | 2022-2023 | Auvelity |
| Vanda Pharmaceuticals INC. | $79.53 | 2021 | |
| Lundbeck LLC | $60.86 | 2021-2023 | Rexulti |
| Abbvie INC. | $51.39 | 2021-2022 | |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $47.41 | 2021-2023 | |
| Adlon Therapeutics L.P. | $26.57 | 2021 | |
| Eisai INC. | $24.89 | 2021 | |
| Hologic Sales and Service, LLC | $23.71 | 2025 | Omni Hysteroscope, Fluent Fluid Management System |
| Corium, LLC | $21.67 | 2023 | Azstarys |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Jazz Pharmaceuticals INC. | $20.95 | 2021 | |
| Otsuka America Pharmaceutical, INC. | $14.71 | 2023 | Rexulti |
| Arbor Pharmaceuticals, INC. | $13.68 | 2021 | |
| Merck Sharp & Dohme LLC | $12.28 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw April Anderson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.